Gnta
الشركة عبارة عن شركة طبيه وتعمل في مجال الابحاث عن دواء يعمل على تفتيت الخلايا السرطانيه
فما فيه مجال لمناقشه شرعيتها..........و ما قصر الوزير في المشاركه
Profile
Genta Incorporated, a biopharmaceutical company, engages in the identification, development, and commercialization of drugs for the treatment of cancer and related diseases in the United States. The company?s research portfolio consists of two programs, DNA/RNA Medicines and Small Molecules. The DNA/RNA Medicines program includes drugs that are based on using modifications of either DNA or RNA as drugs that can be used to treat disease. This program includes technologies, such as antisense, decoys, and small interfering or micro RNAs. Its lead product Genasense, designed to block the production of a protein known as Bcl-2, is used for the treatment of malignant melanoma, chronic lymphocytic leukemia, multiple myeloma, acute myelocytic leukemia, nonsmall-cell lung cancer, prostate cancer, small-cell lung cancer, breast cancer, colorectal cancer, nonHodgkin?s lymphoma, kidney cancer, pancreatic cancer and other solid tumors, Waldenstrom?s macroglobulinemia, hepatocellular carcinoma, childhood solid tumors, and adult solid tumors. The Small Molecules program includes drugs that are based on gallium-containing compounds. Its lead product Ganite, which is in phase II clinical study, is used for the treatment of cancer-related hypercalcemia that is resistant to hydration used primarily for patients with malignant lymphoma, bladder cancer, nonHodgkin?s lymphoma, and other cancer types. The company was founded in 1988 and is based in Berkeley Heights, New Jersey.
(